公开(公告)号：US20240398787A1

公开(公告)日：2024-12-05

申请号：US18437732

申请日：2024-02-09

Applicant: AbbVie Inc. ,  Allergan Pharmaceuticals International Limited

Inventor： Kumar Budur ,  Ludmyla Rekeda ,  Willie R. Earley

IPC: A61K31/495 ,  A61P25/24

Abstract: The present disclosure provides methods for the treatment of major depressive disorder by administering cariprazine or a pharmaceutically acceptable salt thereof.

公开(公告)号：US20240100072A1

公开(公告)日：2024-03-28

申请号：US17975267

申请日：2022-10-27

Applicant: AbbVie Inc.

Inventor： Maurizio F. Facheris ,  Michael Gold ,  Weining Z. Robieson ,  Melissa Vos ,  Amy M. Spiegel ,  Nahome Tezera Fisseha ,  Janet A. Benesh ,  George Liossis ,  Kumar Budur

IPC: A61K31/661 ,  A61K9/00 ,  A61P25/16

CPC classification number: A61K31/661 ,  A61K9/0019 ,  A61P25/16

Abstract: The present disclosure relates to safe and effective subcutaneously administered treatments for advanced Parkinson's disease.

公开(公告)号：US20230149392A1

公开(公告)日：2023-05-18

申请号：US18050907

申请日：2022-10-28

Applicant: AbbVie Inc. ,  Allergan Pharmaceuticals International Limited

Inventor： Kumar Budur ,  Ludmyla Rekeda ,  Willie R. Earley

IPC: A61K31/495 ,  A61P25/24

CPC classification number: A61K31/495 ,  A61P25/24

Abstract: The present disclosure provides methods for the treatment of major depressive disorder by administering cariprazine or a pharmaceutically acceptable salt thereof.